KZR News - Candlesense

Kezar Life Sciences to Participate in Two Upcoming Investor Conferences

(NASDAQ:KZR) SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unme...

Investor

11 days ago

Kezar Life Sciences Reports Second Quarter 2025 Financial Results and Provides Business Update

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in im...

What impact could potential collaborations or licensing deals have on the company's growth trajectory? Has the company provided guidance for future quarters, and how does that align with analyst expectations? What are the potential risks or uncertainties associated with the clinical trial outcomes for zetomipzomib?

Earnings

26 days ago